Amyloid Precursor Protein and Alzheimer’s Disease
International Journal of Molecular Sciences · 30.09.2023 · 24 (19) · 14794
DOI: 10.3390/ijms241914794 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.09.2023. Verfasst von Kseniia S Orobets und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Hauptthemen laut MEDLINE: Alzheimer Disease. Die Arbeit wurde bisher 133-mal zitiert (Crossref) und nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research, Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders associated with age or inherited mutations. It is characterized by severe dementia in the late stages that affect memory, cognitive functions, and daily life overall. AD progression is linked to the accumulation of cytotoxic amyloid beta (Aβ) and hyperphosphorylated tau protein combined with other pathological features such as synaptic loss, defective energy metabolism, imbalances in protein, and metal homeostasis. Several treatment options for AD are under investigation, including antibody-based therapy and stem cell transplantation. Amyloid precursor protein (APP) is a membrane protein considered to play a main role in AD pathology. It is known that APP in physiological conditions follows a non-amyloidogenic pathway; however, it can proceed to an amyloidogenic scenario, which leads to the generation of extracellular deleterious Aβ plaques. Not all steps of APP biogenesis are clear so far, and these questions should be addressed in future studies. AD is a complex chronic disease with many factors that contribute to disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA.
ORCID-Profile: Andrey L Karamyshev
Förderung
- the Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research
- Center of Excellence for Translational Neuroscience and Therapeutics (CTNT) and the TTUHSC Office of Research
Zitieren
APA
Orobets, K. S., & Karamyshev, A. L. (2023). Amyloid Precursor Protein and Alzheimer’s Disease. International Journal of Molecular Sciences, 24(19), 14794. https://doi.org/10.3390/ijms241914794
Vancouver
Orobets KS, Karamyshev AL. Amyloid Precursor Protein and Alzheimer’s Disease. International Journal of Molecular Sciences. 2023;24(19):14794. doi:10.3390/ijms241914794
BibTeX
@article{Orobets2023,
author = {Orobets, Kseniia S and Karamyshev, Andrey L},
title = {Amyloid Precursor Protein and Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {19},
pages = {14794},
doi = {10.3390/ijms241914794}
}
EUVIMED